Targeted Treatment Reverses Increased Left Cardiac Work in Unilateral vs. Bilateral Primary Aldosteronism

Am J Hypertens. 2024 Oct 14;37(11):884-892. doi: 10.1093/ajh/hpae087.

Abstract

Background: The incidence of cardiovascular complications may be higher in unilateral than bilateral primary aldosteronism (PA). We compared noninvasive hemodynamics after targeted therapy of bilateral vs. unilateral PA.

Methods: Adrenal vein sampling was performed, and hemodynamics recorded using radial artery pulse wave analysis and whole-body impedance cardiography (n = 114). In 40 patients (adrenalectomy n = 20, spironolactone-based treatment n = 20), hemodynamic recordings were performed after 33 months of PA treatment.

Results: In initial cross-sectional analysis, 51 patients had bilateral and 63 unilateral PA. The mean ages were 50.6 and 54.3 years (P = 0.081), and body mass indexes 30.3 and 30.6 kg/m2 (P = 0.724), respectively. Aortic blood pressure (BP) and cardiac output did not differ between the groups, but left cardiac work was ~10% higher in unilateral PA (P = 0.022). In the follow-up study, initial and final BPs in the aorta were not significantly different, while initial cardiac output (+13%, P = 0.015) and left cardiac work (+17%, P = 0.009) were higher in unilateral than bilateral PA. After median treatment of 33 months, the differences in cardiac load were abolished, and extracellular water volume was reduced by 1.3 and 1.4 l in bilateral vs. unilateral PA, respectively (P = 0.814).

Conclusions: These results suggest that unilateral PA burdens the heart more than bilateral PA, providing a possible explanation for the higher incidence of cardiac complications in unilateral disease. A similar reduction in aldosterone-induced volume excess was obtained with targeted surgical and medical treatment of PA.

Keywords: blood pressure; cardiac work; hypertension; primary aldosteronism.

Publication types

  • Comparative Study

MeSH terms

  • Adrenalectomy*
  • Adult
  • Aged
  • Cardiac Output / drug effects
  • Cardiography, Impedance
  • Cross-Sectional Studies
  • Female
  • Hemodynamics / drug effects
  • Humans
  • Hyperaldosteronism* / complications
  • Hyperaldosteronism* / drug therapy
  • Hyperaldosteronism* / physiopathology
  • Hyperaldosteronism* / surgery
  • Male
  • Middle Aged
  • Mineralocorticoid Receptor Antagonists* / therapeutic use
  • Pulse Wave Analysis
  • Spironolactone* / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left / drug effects

Substances

  • Mineralocorticoid Receptor Antagonists
  • Spironolactone